Novadaq (NVDQ) 6-K NOVADAQ to Present at the 35th Annual J.P. Morgan Healthcare Conference

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

For the month of December 2016

Commission File Number: 001-35446

NOVADAQ TECHNOLOGIES INC.
(Translation of registrant's name into English)

5090 Explorer Drive
Suite 202, Mississauga
Ontario, Canada L4W 4T9
(Address of registrant’s principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [   ]      Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes [   ]     No [X]

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NOVADAQ TECHNOLOGIES INC.
	(Registrant)
Date: December 6, 2016	/s/ Roger Deck
	Roger Deck
	Chief Financial Officer

EXHIBIT INDEX

Exhibit	Description
99.1	Press Release